Ischemic post-conditioning facilitates brain recovery after stroke by promoting Akt/mTOR activity in nude rats

J Neurochem. 2013 Dec;127(5):723-32. doi: 10.1111/jnc.12342. Epub 2013 Jul 8.

Abstract

While pre-conditioning is induced before stroke onset, ischemic post-conditioning (IPostC) is performed after reperfusion, which typically refers to a series of mechanical interruption of blood reperfusion after stroke. IPostC is known to reduce infarction in wild-type animals. We investigated if IPostC protects against brain injury induced by focal ischemia in Tcell-deficient nude rats and to examine its effects on Akt and the mammalian target of rapamycin (mTOR) pathway. Although IPostC reduced infarct size at 2 days post-stroke in wild-type rats, it did not attenuate infarction in nude rats. Despite the unaltered infarct size in nude rats, IPostC increased levels of phosphorylated Akt (p-Akt) and Akt isoforms (Akt1, Akt2, Akt3), and p-mTOR, p-S6K and p-4EBP1 in the mTOR pathway, as well as growth associated Protein 43 (GAP43), both in the peri-infarct area and core, 24 h after stroke. IPostC improved neurological function in nude rats 1-30 days after stroke and reduced the extent of brain damage 30 days after stroke. The mTOR inhibitor rapamycin abolished the long-term protective effects of IPostC. We determined that IPostC did not inhibit acute infarction in nude rats but did provide long-term protection by enhancing Akt and mTOR activity during the acute post-stroke phase. Post-conditioning did not attenuate infarction in nude rats measured 2 days post-stroke, but improved neurological function in nude rats and reduced brain damage 30 days after stroke. It resulted in increased-activities of Akt and mTOR, S6K and p-4EBP1. The mTOR inhibitor rapamycin abolished the long-term protective effects of IPostC.

Keywords: Akt; T cells; ischemic post-conditioning; mTOR; stroke.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • Immunosuppressive Agents / pharmacology
  • Ischemic Postconditioning / methods*
  • Male
  • Proto-Oncogene Proteins c-akt / metabolism*
  • Rats
  • Rats, Nude
  • Rats, Sprague-Dawley
  • Recovery of Function / physiology*
  • Ribosomal Protein S6 Kinases, 70-kDa / metabolism
  • Sirolimus / pharmacology
  • Stroke / metabolism*
  • Stroke / physiopathology
  • Stroke / therapy*
  • T-Lymphocytes / physiology
  • TOR Serine-Threonine Kinases / antagonists & inhibitors
  • TOR Serine-Threonine Kinases / metabolism*

Substances

  • Immunosuppressive Agents
  • mTOR protein, rat
  • Akt1 protein, rat
  • Proto-Oncogene Proteins c-akt
  • Ribosomal Protein S6 Kinases, 70-kDa
  • TOR Serine-Threonine Kinases
  • ribosomal protein S6 kinase, 70kD, polypeptide 2
  • Sirolimus